Comments on: U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Patients with Previously Untreated Advanced Melanoma

Comments on: U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Patients with Previously Untreated Advanced Melanoma https://www.worldpharmatoday.com/press-releases/us-food-and-drug-administration-accepts-supplemental-biologics-license-application-for-opdivo-nivolumab-in-patients-with-previously-untreated-advanced-melanoma/ Magazine for the C-level Pharma Executives Tue, 28 Apr 2015 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4